Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agile Therapeutics Inc
(NQ:
AGRX
)
0.6022
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.6022
Bid (Size)
0.2400 (9)
Ask (Size)
0.2407 (5)
Prev. Close
0.6022
Today's Range
0.6022 - 0.6022
52wk Range
0.5040 - 7.000
Shares Outstanding
6,856,229
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023
March 29, 2024
AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Agile Therapeutics: Q4 Earnings Insights
March 28, 2024
Via
Benzinga
Performance
YTD
-67.27%
-67.27%
1 Month
+14.14%
+14.14%
3 Month
-61.89%
-61.89%
6 Month
-67.97%
-67.97%
1 Year
-90.97%
-90.97%
More News
Read More
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
March 28, 2024
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics's Earnings: A Preview
March 27, 2024
Via
Benzinga
Why Agile Therapeutics (AGRX) Stock Is Down 60%
March 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 25, 2024
Via
Benzinga
Agile Therapeutics's Earnings: A Preview
March 21, 2024
Via
Benzinga
Agile Therapeutics Announces Delisting from Nasdaq
March 25, 2024
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 22, 2024
March 22, 2024
Via
Benzinga
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
March 21, 2024
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
March 20, 2024
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 13, 2024
Via
Benzinga
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
March 13, 2024
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
What's Going On With Women Health Focused Agile Therapeutics Stock Today?
February 22, 2024
Via
Benzinga
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
February 22, 2024
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 22, 2024
Via
Benzinga
Why Is Bel Fuse (BELFB) Stock Down 17% Today?
February 22, 2024
Via
InvestorPlace
Why Is Draganfly (DPRO) Stock Down 48% Today?
February 22, 2024
Via
InvestorPlace
Why Is BuzzFeed (BZFD) Stock Up 101% Today?
February 22, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 22, 2024
Via
Benzinga
Why Is Agile Therapeutics (AGRX) Stock Up 87% Today?
February 22, 2024
Via
InvestorPlace
Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
February 22, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 22, 2024
Via
InvestorPlace
5 Value Stocks In The Healthcare Sector
February 19, 2024
Via
Benzinga
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
February 15, 2024
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.